Player FM - Internet Radio Done Right
28 subscribers
Checked 1+ y ago
Aggiunto otto anni fa
Contenuto fornito da Minneapolis Heart Institute Foundation. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Minneapolis Heart Institute Foundation o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !
Vai offline con l'app Player FM !
Atrial Fibrillation: New Agents for Stroke Prevention
Manage episode 155728432 series 1166503
Contenuto fornito da Minneapolis Heart Institute Foundation. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Minneapolis Heart Institute Foundation o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Dr. R. Jeffrey Westcott, Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute, discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.
12 episodi
Atrial Fibrillation: New Agents for Stroke Prevention
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Manage episode 155728432 series 1166503
Contenuto fornito da Minneapolis Heart Institute Foundation. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Minneapolis Heart Institute Foundation o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Dr. R. Jeffrey Westcott, Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute, discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.
12 episodi
ทุกตอน
×M
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Dr. Raed H. Abdelhadi , Cardiac Electrophysiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital , reviews the background for the Riata ICD recall and the available data on the Riata ICD lead, explains the preliminary results for the Riata Multicenter Study, discusses the challenges regarding screening and management and summarizes the Riata Summit.…
M
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Dr. Steven R. Goldsmith , Professor of Medicine at the University of Minnesota , Director of the Heart Failure Program at Hennepin County Medical Center , and Director of the Minnesota Heart Failure Consortium , explains the importance of congestion as a contributor to the pathophysiology of acute heart failure, describes the limits of current decongestive strategies and the promise of newer modalities and discusses emerging insights concerning the relationship between congestion and the cardiorenal syndrom in acute heart failure.…
M
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Dr. R. Jeffrey Westcott , Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute , discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.…
M
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Dr. Timothy Henry , Director of Research at the Minneapolis Heart Institute Foundation , and Dr. Jay Traverse , Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital , review the results of the LateTIME, SCIPIO and CADUCEUS trials.
M
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Dr. Thomas Knickelbine , Director of Preventive Cardiology at the Minneapolis Heart Institute at Abbott Northwestern Hospital discusses US population risk factors, explains how to approach patients with statin intolerance, describes the current approaches to treatment of non-HDL cholesterol and Metabolic Syndrome and outlines MHI prevention goals and future vision.…
M
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Acute Aortic Intramural Hematoma: an analysis from the International Registry of Acute Aortic Dissection - Presented by Dr. Kevin M. Harris Circadian Dependence of Infarct Size and Left-Ventricular Function Following ST-Elevation Myocardial Infarction - Presented by Dr. Ronald Reiter Cardiogenic Shock in Cardiac Arrest No Longer a Contraindication for Therapeutic Hypothermia - Presented by Fourth-Year Medical Student, Kalie Y. Kebed Prevalence of Premature Coronary Heart Disease and Female Gender in Patients Presenting with ST-Elevation Myocardial Infarction - Presented by Dr. Michael D. Miedema…
M
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Dr. Steve Levin , Vascular Fellow at the University of Minnesota , defines critical limb ischemia, identifies the evolving role of drug eluting stents in the treatment of peripheral arterial disease and compares how drug eluting stents have performed relative to balloon angioplasty and bare metal stenting in patients suffering from critical limb ischemia.…
Dr. Benjamin Sun , Chair of Cardiac, Thoracic and Transplant Surgery at the Minneapolis Heart Institute at Abbott Northwestern Hospital , identifies which valves can be repaired, explains why we don't repair valves more frequently and describes when valve replacement is still preferred.
M
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Dr. Alan J. Bank , Medical Director of Research at United Heart and Vascular Clinic , and Associate Professor of Cardiology at the University of Minnesota , describes the components of a CRT Center of Excellence, explains the mechanisms of action of CRT, discusses the importance of mechanical dyssynchrony in heart failure, and describes the effects of CRT in patients with NYHA Class II heart failure.…
M
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Dr. Nedaa Skeik , Vascular Medicine Consultant at the Minneapolis Heart Institute® at Abbott Northwestern Hospital , explains different treatment modalities for deep vein thrombosis (DVT), describes the history of inferior vena cava (IVC) filters, lists indications and complications (common and rare) of IVC filters, and explains identification and management of arterial pseudoaneurysm as a rare complication of IVC filters.…
M
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Dr. Barry J. Maron , Director of the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute at Abbott-Northwestern Hospital looks explains how to risk stratify hypertrophic cardiomyopathy (HCM) patients and describes the role of the implantable cardioverter defibrillator in HCM patients.…
M
Minneapolis Heart Institute Foundation Cardiology Grand Rounds
Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott-Northwestern Hospital , Dr. Robert Hauser , su mmarizes pacing hemodynamics, d escribes the value of cardiac synchronization, and e xplains ICD reliability and patient longevity.
Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.